On October 25, 2011, Anthony Cataldo resigned as the Company’s Chairman of the Board, and Michael Handelman resigned as the Company’s Chief Financial Officer.  Mr. Cataldo and Mr. Handelman currently serve as the Chief Executive Officer and Chief Financial Officer, respectively, of Genesis Biopharma, Inc., a public biopharmaceutical company that recently acquired substantial operating assets.  Mr. Cataldo and Mr. Handelman informed the Company that they resigned in order to spend their full time dedicated to the operations of Genesis Biopharma, Inc.